Logo American Journal of Case Reports

Call: 1.631.629.4328
Mon-Fri 10 am - 2 pm EST

Contact Us

Logo American Journal of Case Reports Logo American Journal of Case Reports Logo American Journal of Case Reports

19 December 2019: Articles  Brazil

Syringoid Eccrine Carcinoma in the Abdominal Wall: A Rare Case Report and Literature Review

Challenging differential diagnosis, Diagnostic / therapeutic accidents, Rare disease, Educational Purpose (only if useful for a systematic review or synthesis)

Miguel Augusto Pereira ABCDEF 1*, Luciana Pantaleão AF 2, Mayra Rochael AF 2

DOI: 10.12659/AJCR.919444

Am J Case Rep 2019; 20:1896-1901

0 Comments

Abstract

BACKGROUND: Syringoid eccrine carcinoma (SEC) is an extremely rare malignant adnexal neoplasm derived from eccrine sweat glands, of unknown pathogenesis. We report a case of this rare entity presenting in the abdomen, which is the only one reported in this area and the only case of SEC in a patient with so many comorbidities.

CASE REPORT: A 58-year-old black male from Brazil reported a nodular lesion in the abdomen with a progressive increase in size and pain and local burning sensation. The histopathological examination showed a syringoid eccrine carcinoma.

CONCLUSIONS: We present a rare case of SEC and did an extensive literature review in order to describe the clinical characteristics, histopathological findings, immunohistochemical profile, treatments, and difficulties found in the diagnosis of this tumor. To avoid misdiagnosis, we gave special attention to biopsy quality.

Keywords: Carcinoembryonic Antigen, Diagnosis, Differential, Immunohistochemistry, Sweat Gland Neoplasms, Abdominal Wall, Carcinoma, Eccrine Glands, Rare Diseases, Syringoma

Background

Syringoid eccrine carcinoma (SEC) is an extremely rare malignant adnexal neoplasm derived from eccrine sweat glands, whose pathogenesis has not yet been well defined. It equally affects males and females, is most often present in the fourth to seventh decade of life, and represents less than 0.01% of all skin cancers [1–3]. This tumor is considered extremely invasive, locally destructive, slow growing and high recurrence, but difficult to metastasize.

This type of carcinoma has been referred to by many names throughout history, probably due to the different stages of differentiation found in the lesion [1]. It was first described in 1969 by Freeman and Winklemann as a basal cell tumor with eccrine differentiation [4]. Thus, from the 1970s onwards, other names emerged, including malignant syringoma [5], sweat gland carcinoma with syringomatous characteristics [6], eccrine epithelioma [4,7] and sclerosing carcinoma (syringomatosis) of sweat duct [8]. However, the term SEC is more appropriate because of cytological and enzymatic features that differ from basal cell carcinoma [9]. In this article, we report a case of a 58-year-old man with this rare malignant neoplasia in an unusual location.

Case Report

PATHOLOGICAL FINDINGS:

At the macroscopic examination, a skin fragment measuring 7.0×5.0×1.5 cm was observed, with dark brown epidermis showing a slightly delimited paracentral lesion slightly elevated measuring 1.5×1.5 cm. A 2.0-cm central white linear scar was observed, and the lesion was located 2.0 cm from the nearest margin. The cut surface was white and elastic, with a thickened area in the area of the described lesion.

The histopathological examination revealed a syringoid eccrine carcinoma, which consisted of atypical epithelial cells forming cords and tubules in the midst of a compact dense collagen matrix, infiltrating even the hypodermis (Figure 2). There were regular acanthosis of the epidermis, multiple foci of perineural invasion, and absence of vascular invasion (Figures 2, 3). No usual skin adnexal were observed. There were circumferential and deep compromised surgical limits. The material was submitted to immunohistochemical study, showing reactivity for S100, CK7, EMA (Epithelial Membrane Antigen), p-CEA (CD66e), and SMA (alpha smooth muscle actin), as well as negativity for CK20 (Figure 4).

The treatment used by the medical team was surgical excision under local anesthesia, and no flap was required. There was no recurrence of the lesion so far (follow-up of 15 months); however, surgery is being scheduled to increase the surgical margin.

Discussion

SEC usually manifests as a subcutaneous plaque or nodule with slow growth and poorly delimited margins, arising between the fifth and sixth decade of life, which was compatible with the age of the patient presented. However, the location in which the lesion was found is somewhat unusual, since SEC predominates in the area of the head (scalp) and neck. However, in the literature, there are cases reported in the trunk, extremities, nipples, vulva, and ungual complex, as well as in the scapular region, plantar region, and even in the auditory canal [1,9–15].

The histology of SEC can range from a well-differentiated to a more anaplastic lesion, with little evidence of eccrine differentiation. It is characterized by numerous infiltrative structures, connected and covered by squamous or basaloid cells of hyperchromatic nuclei, in a fibrocolagenous stroma (desmoplastic reaction), extending through the dermis, underlying subcutaneous tissue or skeletal muscle, with perineural infiltration. Tumor cells can organize into nests, cords, or tubules, some of which exhibit a morphology resembling tadpole-like syringoma due to the cords of epithelial tissue. Cytonuclear atypia is not very evident, as is the presence of mitotic activity, which may even be absent [1,11,14,16]. The epithelial component of the tumor may show a cribriform pattern in focus (Figure 3), which makes it difficult to distinguish from other tumors [3].

The immunohistochemical profile of SEC is quite varied, with the carcinoembryonic antigen (CEA) being the most consistent marker [17]; other markers generally present are high and low molecular weight cytokeratins, the epithelial membrane antigen (EMA), PS100, and Leu M1. In addition, the immunohistochemical study may exclude the possibility of breast cancer in the differential diagnosis.

Despite the apparent poor prognosis, when considering only some characteristics of the tumor, such as infiltration of disfiguring character (especially in the face) or high recurrence, and it is difficult to observe regional metastases, distant metastases or involvement of the lymphatic chain [1,18–20].

The present case was a diagnostic challenge since its initial evaluation. At the time, the clinical diagnostic hypotheses raised were adnexal carcinoma, cutaneous calcinosis, dermatofibrosarcoma protuberans, or panniculitis. The malignant characteristics of the lesion, observed under microscopy, also suggested cutaneous metastasis of adenocarcinoma of unknown primary site, adenoid cystic carcinoma (ADC), and SEC. In the differential diagnosis with ADC, perineural infiltration and histological presentation might resemble ADC with a cribriform morphological pattern; however, the positivity for CEA and S100 in our patient would be more consistent with the tubular pattern [21]. Thus, in addition to the immunohistochemical pattern disagreeing with the morphological pattern, there is no accumulation of mucin, as occurs in ADC, favoring the diagnosis of SEC [3,14,19,17]. Imaging studies have been reported to be important but for delimiting the lesion, but not for diagnosis of SEC [11], or searching for metastases [9,10,15].

Every physician should pay attention to the biopsy quality, which should be of adequate size and depth. In some cases, a superficial biopsy (e.g., shaved off) may not adequately represent the architectural and depth of infiltration patterns, and are thus erroneously interpreted as being benign syringomas, trichoepitheliomas, trichoadenomas, or squamous cell carcinomas due to the microscopic appearance. Thus, malignant lesions such as SEC can be mistaken for benign lesions such as benign syringomas. If ductal differentiation is poorly represented, an erroneous diagnosis of basal cell carcinoma can occur [22]. The importance of biopsy quality is demonstrated by a study involving microcystic adnexal carcinoma of the skin conducted by Leboit, in which 9 of the 17 lesions studied were initially misdiagnosed due to the small size of the biopsy specimen [23], which is also a mistake made in the diagnosis of SEC. It should be noted that this is an extremely infiltrating and disfiguring lesion, having serious consequences for patients.

In this case, the criterion standard treatment was used, so surgical resection of the lesion was performed. This method is considered to be optimal and the main treatment choice, since the other option, radiation, is rarely used since the tumor is considered resistant, but it has been reported in the literature as adjuvant therapy [11].

Follow-up is necessary to evaluate recurrence, since this type of tumor is frequently recurrent, with about 40% to 60% of patients presenting within 6 months to 30 years after excision [22].

Conclusions

In conclusion, we report a rare case of SEC presenting in the upper left quadrant of the abdomen. To the best of our knowledge, is the only case reported in this area and the only case of SEC in a patient with so many comorbidities. We present another well-illustrated case of this rare entity in order to guide dermatologists and pathologists in this difficult diagnosis, especially regarding the importance of a biopsy that adequately considers the lesion size and depth, thus avoiding serious diagnostic errors.

References:

1.. El khannoussi B, Hechlaf H, Lalya I, Syringomatous carcinoma: Case report of a rare tumor entity: Pan Afr Med J, 2012; 12; 76, pmid: 23077697

2.. Tulenko JF, Conway H, An analysis of sweat gland tumors: Surg Gynecol Obstet, 1965; 121; 343-48, pmid: 14320386

3.. Moy RL, Rivkin JE, Lee H, Syringoid eccrine carcinoma: J Am Acad Dermatol, 1991; 24(5); 857-60, pmid: 2050853

4.. Freeman RG, Winkelmann RK, Basal cell tumor with eccrine differentiation (eccrine epithelioma): Arch Dermatol, 1969; 100; 234-42, pmid: 5797968

5.. Glatt HJ, Proia AD, Tsoy EA, Malignant syringoma of the eyelid: Opthalmology, 1984; 91; 987-90

6.. Lipper S, Peiper SC, Sweat gland carcinoma with syringomatous features: A light microscopic and ultrastructural study: Cancer, 1979; 44; 157-63, pmid: 455242

7.. Sanchez NP, Winkelmann RK, Basal cell tumor with eccrine differentiation (eccrine epithelioma): J Am Acad Dermatol, 1982; 6; 514-18, pmid: 6210714

8.. Cooper PH, Mills SE, Leonard DD, Sclerosing sweat duct (syringomatous) carcinoma: Am J Surg Pathol, 1985; 9; 422-33, pmid: 4091180

9.. Gregurek-Novak T, Talan-Hranilović J, Troskot N, Syringoid eccrine carcinoma: J Eur Acad Dermatol Venereol, 2001; 15; 143-46, pmid: 11495522

10.. Won YY, Suh DW, Lew BL, Sim WY, Syringoid eccrine carcinoma of the thigh: Ann Dermatol, 2017; 29; 6, pmid: 28223740

11.. Ballardini P, Margutti G, Pedriali M, Querzoli P, Metastatic syringoid eccrine carcinoma of the nipple: Int Med Case Rep J, 2012; 5; 45-48, pmid: 23754922

12.. Piovano E, Ferrero A, Ravarino N, Syringoid eccrine carcinoma: Case report of a rare tumor occasionally detected in the vulva: Gynecol Oncol Case Rep, 2011; 1; 17-19, pmid: 24371593

13.. Grady JF, Boumendjel Y, Tahniyath MS, Subungual syringoid eccrine carcinoma of the great toe nail complex: A case report: J Am Podiatr Med Assoc, 2014; 104; 504-7, pmid: 25275739

14.. Cho WC, Wagner B, Gulosh M, Elaba Z, Syringoid eccrine carcinoma of the foot: Report of a rare cutaneous adnexal neoplasm: Int J Surg Pathol, 2017; 25; 659-64, pmid: 28552016

15.. Ahmed MK, Ishino T, Hirakawa K, Arihiro K, Syringoid eccrine carcinoma of external auditory canal: A case report: Auris Nasus Larynx, 2010; 37; 519-21, pmid: 20172670

16.. Terushkin E, Leffell DJ, Futoryan T, Squamoid eccrine ductal carcinoma: A case report and review of the literature: Am J Dermatopathol, 2010; 32; 287-92, pmid: 20010402

17.. Sidiropoulos M, Sade S, Al-Habeeb A, Ghazarian D, Syringoid eccrine carcinoma: A clinicopathological and immunohistochemical study of four cases: J Clin Pathol, 2011; 64; 788-92, pmid: 21642659

18.. Werbrouck A, Wechsler J, Blin H, Gontier MF, [A palpebral tumor]: Ann Pathol, 2006; 26; 135-37, pmid: 16791128 [in French]

19.. Malmusi M, Collina G, Syringoid eccrine carcinoma: A case report: Am J Dermatopathol, 1997; 19; 533-35, pmid: 9335248

20.. Goto M, Sonoda T, Shibuya H, Digital syringomatous carcinoma mimicking basal cell carcinoma: Br J Dermatol, 2001; 144; 438-39, pmid: 11251603

21.. Bradley PJ, Adenoid cystic carcinoma of the head and neck: A review: Curr Opin Otolaryngol Head Neck Surg, 2004; 12; 127-32, pmid: 15167050

22.. Hoppenreijs VP, Reuser TT, Mooy CM, Syringomatous carcinoma of the eyelid and orbit: A clinical and histopathological challenge: Br J Ophthalmol, 1997; 81; 668-72, pmid: 9349155

23.. Leboit PE, Sexton M, Microcystic adnexal carcinoma of the skin: J Am Acad Dermatol, 1993; 29; 609-18, pmid: 7691906

In Press

Case report  China

Thrombolytic Therapy After Return of Spontaneous Circulation in Patients With STEMI From Medically Underdev...

Am J Case Rep In Press; DOI: 10.12659/AJCR.949976  

Case report  Greece

Multilevel Laminectomy for Lumbar Spinal Stenosis With Low Back Pain in Achondroplasia: A Case Report

Am J Case Rep In Press; DOI: 10.12659/AJCR.950290  

Case report  Italy

Fractional CO₂ Laser (SCAR3 Scanner) for a Hypertrophic Retracting Cleft Lip Scar: A Case Report

Am J Case Rep In Press; DOI: 10.12659/AJCR.950607  

Case report  Saudi Arabia

Postoperative Corneal Dellen Following PreserFlo MicroShunt: A Case Report

Am J Case Rep In Press; DOI: 10.12659/AJCR.950985  

Most Viewed Current Articles

07 Dec 2021 : Case report  USA 17,691,734

Edwardsiella tarda: A Classic Presentation of a Rare Fatal Infection, with Possible New Background Risk Fac...

DOI :10.12659/AJCR.934347

Am J Case Rep 2021; 22:e934347

06 Dec 2021 : Case report  Brazil 164,491

Lipedema Can Be Treated Non-Surgically: A Report of 5 Cases

DOI :10.12659/AJCR.934406

Am J Case Rep 2021; 22:e934406

21 Jun 2024 : Case report  China (mainland) 113,090

Intracranial Parasitic Fetus in a Living Infant: A Case Study with Surgical Intervention and Prognosis Anal...

DOI :10.12659/AJCR.944371

Am J Case Rep 2024; 25:e944371

0:00

07 Mar 2024 : Case report  USA 59,175

Neurocysticercosis Presenting as Migraine in the United States

DOI :10.12659/AJCR.943133

Am J Case Rep 2024; 25:e943133

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

American Journal of Case Reports eISSN: 1941-5923
American Journal of Case Reports eISSN: 1941-5923